U.S. markets close in 5 hours 38 minutes
  • S&P 500

    4,452.06
    -3.42 (-0.08%)
     
  • Dow 30

    35,036.33
    +238.33 (+0.68%)
     
  • Nasdaq

    14,948.50
    -99.20 (-0.66%)
     
  • Russell 2000

    2,269.31
    +21.23 (+0.94%)
     
  • Crude Oil

    75.26
    +1.28 (+1.73%)
     
  • Gold

    1,753.90
    +2.20 (+0.13%)
     
  • Silver

    22.71
    +0.28 (+1.27%)
     
  • EUR/USD

    1.1710
    -0.0008 (-0.07%)
     
  • 10-Yr Bond

    1.4730
    +0.0130 (+0.89%)
     
  • GBP/USD

    1.3726
    +0.0045 (+0.33%)
     
  • USD/JPY

    110.8190
    +0.1340 (+0.12%)
     
  • BTC-USD

    43,485.09
    +248.59 (+0.57%)
     
  • CMC Crypto 200

    1,082.81
    -18.71 (-1.70%)
     
  • FTSE 100

    7,060.83
    +9.35 (+0.13%)
     
  • Nikkei 225

    30,240.06
    -8.75 (-0.03%)
     

U.S. to buy 1.4 mln additional doses of Regeneron's COVID-19 therapy

  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Sept 14 (Reuters) - Regeneron Pharmaceuticals Inc said on Tuesday the U.S. government will buy 1.4 million additional doses of its COVID-19 antibody cocktail, REGEN-COV.

The cocktail, a combination of two antibodies casirivimab and imdevimab, was authorized in November for emergency use by the U.S. Food and Drug Administration.

The new agreement brings the total purchased by the U.S. government to nearly 3 million doses. (Reporting by Dania Nadeem in Bengaluru; Editing by Anil D'Silva)